- Breast Cancer Groups “Team Up” with $6.4 Million Grant to Advance Promising Treatments for Aggressive, Triple Negative Breast Cancer. Read about it here.
- Three promising but early research studies on a class of drugs called PARP Inhibitors which may work preferentially for hereditary cancers were presented at the 2009 American Society of Clinical Oncology Annual Conference last week in Orlando. Click here to find out more.
Research Studies:
- Lesbian and bisexual survivors are needed for a breast cancer research study. The information gained from this research into the well-being and quality of life of lesbian and bisexual breast cancer survivors will be used to develop programs and services designed to reduce health disparities. If you choose to join this study, you will be asked to take part in a phone survey that will last approximately 35 minutes. The survey can be taken from anywhere in the country. Questions about your health, medical history, sexual orientation, and demographics will be asked. One hundred women are needed for this study. The study is being conducted by Ulrike Boehmer, PhD, at the Boston University School of Public Health. Click here to sign-up.
